ADMA Biologics Inc (ADMA) earnings
Quarterly and annual ADMA reports and results, each read against the price at its own news timestamp. Back to the ADMA overview →
3 measured ADMA earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +3.26% | +2.55% | |
| Form 10-Q ADMA BIOLOGICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +3.26% | +2.55% | |
| ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026 | Press release | +0.46% | +0.00% |
Keep exploring
More ADMA: analyst actions → · SEC filings → · ADMA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AstraZeneca PLC Ordinary Shares (AZN) | 1,632 | +0.03% | 54% |
| Alexion Pharmaceuticals, Inc (ALXN) | 1,615 | -0.04% | 49% |
| VARIAN MEDICAL SYSTEMS (VAR) | 1,602 | +0.02% | 51% |
| Mallinckrodt plc (MNK) | 1,581 | +0.04% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.